SYNCOMF

Syncom Formulation (India) Share Price Syncom Formulation (India)

₹11.18
0.11 (0.99%)
29 March, 2024 17:08 BSE: 524470 NSE: SYNCOMFISIN: INE312C01025

Start SIP in Syncom Formulation (India)

Start SIP

Syncom Formulation (India) Performance

Day Range

  • Low 11
  • High 11
₹ 11

52 Week Range

  • Low 5
  • High 19
₹ 11
  • Open Price11
  • Previous Close11
  • Volume1755778

Syncom Formulation (India) Share Price

  • Over 1 Month -21.1%
  • Over 3 Month -24.61%
  • Over 6 Month 32.31%
  • Over 1 Year 124.05%

Syncom Formulation (India) Key Statistics

P/E Ratio 39.8
PEG Ratio 0.7
Market Cap Cr 1,051
Price to Book Ratio 4.1
EPS 0.2
Dividend 0
Relative Strength Index 28.24
Money Flow Index 36.68
MACD Signal -0.82
Average True Range 0.7
Syncom Formulation (India) Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 63625961
Operating Expenses Qtr Cr 57565355
Operating Profit Qtr Cr 7666
Depreciation Qtr Cr 1111
Interest Qtr Cr 1111
Tax Qtr Cr 2222
Net Profit Qtr Cr 6648
IndicatorMar 2023
Total Revenue Annual Cr 239
Operating Expenses Annual Cr 205
Operating Profit Annual in Cr 20
Depreciation Cr 5
Interest Annual Cr 3
Tax Annual Cr 6
Net Profit Annual Cr 20
IndicatorMar 2023
Cash from Operating Activity Annual Cr 10
Cash from Investing Activity Annual Cr -45
Cash from Financing Annual Activity Cr 35
Net Cash Flow Annual Cr 1
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 256
Fixed Assets Annual Cr 116
Total Non Current Assets Annual Cr 196
Total Current Assets Annual Cr 181
Total Assets Annual Cr 377
IndicatorMar 2023
Book Value Per Share Annual Rs 3
ROE Annual % 8
ROCE Annual % 11
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 15
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 65646061
Operating Expenses Qtr Cr 58575355
Operating Profit Qtr Cr 7666
Depreciation Qtr Cr 1111
Interest Qtr Cr 1111
Tax Qtr Cr 2222
Net Profit Qtr Cr 7748
IndicatorMar 2023
Total Revenue Annual Cr 239
Operating Expenses Annual Cr 205
Operating Profit Annual in Cr 20
Depreciation Cr 5
Interest Annual Cr 3
Tax Annual Cr 7
Net Profit Annual Cr 20
IndicatorMar 2023
Cash from Operating Activity Annual Cr 11
Cash from Investing Activity Annual Cr -45
Cash from Financing Annual Activity Cr 35
Net Cash Flow Annual Cr 1
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 256
Fixed Assets Annual Cr 69
Total Non Current Assets Annual Cr 196
Total Current Assets Annual Cr 182
Total Assets Annual Cr 378
IndicatorMar 2023
Book Value Per Share Annual Rs 3
ROE Annual % 8
ROCE Annual % 11
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 15

Syncom Formulation (India) Technicals

EMA & SMA

Current Price
₹11.18
0.11 (0.99%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹12.55
  • 50 Day
  • ₹13.47
  • 100 Day
  • ₹13.02
  • 200 Day
  • ₹11.62
  • 20 Day
  • ₹12.65
  • 50 Day
  • ₹14.36
  • 100 Day
  • ₹13.50
  • 200 Day
  • ₹10.91

Syncom Formulation (India) Resistance and Support

PIVOT
₹11.18
Resistance
First Resistance 11.34
Second Resistance 11.51
Third Resistance 11.67
RSI 28.24
MFI 36.68
MACD Single Line -0.82
MACD -0.90
Support
First Resistance 11.01
Second Resistance 10.85
Third Resistance 10.68

Syncom Formulation (India) Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,181,482 218,148,200 100
Week 1,995,709 199,570,875 100
1 Month 1,791,080 179,108,033 100
6 Month 7,940,944 415,231,970 52.29

Syncom Formulation (India) Result Highlights

Syncom Formulation (India) Synopsis

NSE-Medical-Diversified

Syncom Formul. is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 224.64 Cr. and Equity Capital is Rs. 94.00 Cr. for the Year ended 31/03/2023. Syncom Formulation (India) Ltd. is a Public Limited Listed company incorporated on 21/06/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1988PLC047759 and registration number is 047759.
Market Cap 1,048
Sales 246
Shares in Float 46.06
No of funds 2
Yield 1.01
Book Value 4.1
U/D Vol ratio 0.9
LTDebt / Equity
Alpha 0.13
Beta 1.28

Syncom Formulation (India)

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 50.57%50.57%50.57%50.57%
Mutual Funds
Foreign Portfolio Investors
Individual Investors 44.82%44.76%45%44.85%
Others 4.61%4.67%4.43%4.58%

Syncom Formulation (India) Management

Name Designation
Mr. Kedarmal Shankarlal Bankda Exe.Chairman & W T D
Mr. Vijay Shankarlal Bankda Managing Director
Mrs. Rinki Ankit Bankda Whole Time Director
Mr. Krishna Das Neema Independent Director
Mr. Praveen Jindal Independent Director
Mr. Vinod Kumar Kabra Independent Director
Mrs. Ruchi Jindal Independent Woman Director
Mr. Ritesh Kumar Lunkad Addnl.Independent Director
Mr. Ankit Jain Addnl.Independent Director

Syncom Formulation (India) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Syncom Formulation (India) Corporate Action

Date Purpose Remarks
2024-02-14 Quarterly Results
2023-11-08 Quarterly Results
2023-08-14 Quarterly Results
2023-05-29 Audited Results
2023-02-13 Quarterly Results

Syncom Formulation (India) MF Shareholding

Name Amount(cr)

Syncom Formulation (India) FAQs

What is Share Price of Syncom Formulation (India) ?

Syncom Formulation (India) share price is ₹11 As on 29 March, 2024 | 16:54

What is the Market Cap of Syncom Formulation (India) ?

The Market Cap of Syncom Formulation (India) is ₹1050.9 Cr As on 29 March, 2024 | 16:54

What is the P/E ratio of Syncom Formulation (India) ?

The P/E ratio of Syncom Formulation (India) is 39.8 As on 29 March, 2024 | 16:54

What is the PB ratio of Syncom Formulation (India) ?

The PB ratio of Syncom Formulation (India) is 4.1 As on 29 March, 2024 | 16:54

Q2FY23